Researchers are excited about the medication , a groundbreaking dual treatment showing significant outcomes in clinical trials for weight management. It works by targeting several systems: GLP-1 and GIP, that , when stimulated, help influence hunger and boost energy expenditure . Initial observations suggest substantial body reduction and likely im